-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In chronic lymphocytic leukemia (CLL), autonomous autoimmune reactive BCR (B cell receptor) signaling contributes to the survival of tumor cells , and currently established targeted therapy strategies mainly focus on inhibiting oncogenic kinases in the BCR pathway , By depriving the relevant signals, leading to cell death
.
In chronic lymphocytic leukemia (CLL), autonomous autoimmune reactive BCR (B cell receptor) Body) signal contributes to the survival and immunity of tumor cells
However, despite the initial remission of CLL, patients often develop relapsed and refractory disease or eventually progress to Richter syndrome, and treatment options are limited
.
In this study, the researchers proposed the following hypothesis, that is, by targeting the excessive activation of the PI3K/AKT (phosphatidylinositol 3-phosphate/AKT) signaling pathway to trigger the death of CLL cells
.
The results show that genetically overactivating the PI3K/AKT signal transduction pathway or blocking the activity of the inhibitory phosphatase SHIP1 can induce the acute cell death process of CLL cells
Targeting the excessive activation of PI3K/AKT (phosphatidylinositol 3-phosphate/AKT) signaling pathway triggers the death of CLL cells
Acute AKT1 activation is harmful to CLL cells
Acute AKT1 activation is harmful to CLL cellsMechanism studies have shown that inhibition of SHIP1 will cause an increase in AKT activity, resulting in an increase in mitochondrial respiration and an excessive accumulation of reactive oxygen species (ROS), leading to the death of CLL cells with immunogenic characteristics
.
CLL cell survival requires SHIP1 activity to inhibit AKT signaling
CLL cell survival requires SHIP1 activity to inhibit AKT signalingAll in all, the results of this study reveal that CLL cells are heavily dependent on the activity of PI3K/AKT to ensure their continued proliferation and survival, and to avoid ROS-induced cell death .
The results of this study also indicate that SHIP1's transient inhibition or CLL's A potential treatment strategy
.
CLL cells rely heavily on the activity of PI3K/AKT to ensure their continued proliferation and survival, and avoid ROS-induced cell death
Original source:
Ecker, V.
, Stumpf, M.
, Brandmeier, L.
Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia.
Leave a message here
